USPTO serial 79104037
TRIALTROVE
Reviewed by CopyMark Law Group
Reg. 4405071Status 706Registered
- Filing date
- Status date
- Registration date
- Sep 24, 2013
- Examiner
- KAUFMAN, LAURIE R
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with TRIALTROVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] downloadable electronic publications in the nature of [ newsletters, ] reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; downloadable electronic publications, namely, [ newsletters, ] reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet [ ; computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically; magnetic, optical and electronic data recording apparatus for recording of sound, images or data ] | ACTIVE | — |
| 041 | [ Education services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Arranging and conducting of recreation, entertainment, cultural, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; ] Non-downloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet [ ; providing information and consultation services in connection with the above-mentioned services ] | ACTIVE | — |
| 042 | Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; provision of information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; provision of online information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; [ design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] provision of information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; provision of online information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services [ ; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; technological consultancy and advisory services in the technology field of computer hardware and software; computer software design services; technological consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer software design; hosting of websites; technical consultancy and advisory services in the field of computer networks; technical support services, namely, troubleshooting in the nature of diagnosing problems relating to computer hardware, computer software, computer networks and the Internet; computer network design for others, namely, designing on-line services for the search, retrieval, indexing and organisation of data on electronic communication networks and for enhancing the performance and function of such networks; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ] | ACTIVE | — |
| 044 | [ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; ] providing medical information [, consultancy and advisory services ] in the field of pharmaceuticals; medical information in the field of pharmaceuticals; [ dispensing of pharmaceuticals; veterinary services; compilation of medical reports; medical analysis services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; ] information, consultancy and advisory services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare relating to all the aforesaid services provided on-line | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Informa UK Limited
- Other trademarks owned by Informa UK Limited
- Other trademarks owned by Pharma Intelligence U.K. Limited
- Other trademarks owned by Informa UK Limited
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRIALTROVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 22, 2025 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 22, 2025 | INPC | INVALIDATION PROCESSED | — |
| Jul 6, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 6, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Nov 4, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 11, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 14, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Sep 24, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 22, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 16, 2019 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 16, 2019 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Oct 16, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 18, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 24, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 8, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 11, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 21, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 21, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 24, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 24, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 9, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 9, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 19, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 19, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 4, 2013 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2013 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 19, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2013 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 5, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2013 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 27, 2012 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 27, 2012 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 27, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 1, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2012 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 6, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 25, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 16, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2012 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Feb 17, 2012 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Feb 3, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 5, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 15, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 15, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 11, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 10, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |